Skip to main content
Fig. 1 | Alzheimer's Research & Therapy

Fig. 1

From: Biomarker testing in MCI patients—deciding who to test

Fig. 1

Model performance comparison from demographic only to additional CSF. Comparison of model performance of the stepwise approach (black) from demographic information (red) only to additional CSF testing (blue). a. Prognostic discrimination measured with cross-validated Harrell’s C. b. Prognostic accuracy measured with cross-validated 3-year brier scores. A lower brier score indicates a better prognostic accuracy. CSF, cerebrospinal fluid

Back to article page